Why do we need a classification?

It allows us to have a common language. A classification standardises the features by which a disease entity is diagnosed, allows us to study specific diseases and also to instigate appropriate treatments.

What is the WHO Classification of Tumours of the Haemopoietic and Lymphoid Tissues?

This is a joint project between the European Association for Haematopathology and the Society for Haematopathology. It is a worldwide consensus for the classification of haematological malignancies. The latest update is the 4th Edition and was published in 2008. It incorporates morphology, immunophenotypic and genetics features.


The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia


You can read the review here 

IPSS-R MDS Risk Assessment Calculator

Revised International Prognostic Scoring System (IPSS-R) for Myelodysplastic Syndromes Risk Assessment Calculator


Click here

MDS Fact Sheet

MDS Factsheet for GPs General Practicioners

MDS Fact Sheet

Click here

Varicella Vaccine in MDS

Urgent Clarification on varicella vaccine policy

Current advice from the UK MDS Forum is not to give the Live Varicella Vaccine to patients with MDS.

Please read below correspondence between Professor Salisbury and Dr George Follows, the latter on behalf of the CLL Forum, on the varicella vaccine policy.
This is an external link to the British Society for Haematology  Click here

NICE Guideline

Lenalidomide for treating myelodysplastic syndromes (MDS) associated with an isolated deletion 5q cytogenetic abnormality.

NICE logo

Click here

BSH Guidelines

This is an external link to the home of the British Society for Haematology (BSH). 

BSH Logo Strapline RGB

Click here